Opinion of the Scientific Panel on Genetically Modified Organisms on applications (references EFSA-GMO-UK-2005-25 and EFSA-GMO-RX-T45) for the placing on the market of the glufosinate-tolerant genetically modified oilseed rape T45, for food and feed uses, import and processing and for renewal of the authorisation of oilseed rape T45 as existing product, both under Regulation (EC) No 1829/2003 from Bayer CropScience[1]

Tabs

Article
Panel on Genetically Modified Organisms
doi
10.2903/j.efsa.2008.635
Panel members at the time of adoption
Hans Christer Andersson, Salvatore Arpaia, Detlef Bartsch, Josep Casacuberta, Howard Davies, Lieve Herman, Marc De Loose, Niels Hendriksen, Sirpa Kärenlampi, Jozsef Kiss, Ilona Kryspin-Sørensen, Harry Kuiper, Ingolf Nes, Nickolas Panopoulos, Joe Perry, Annette Pöting, Joachim Schiemann, Willem Seinen, Jeremy Sweet, and Jean-Michel Wal.
Acknowledgements

The GMO Panel wishes to thank Patrick Du Jardin, G. Kleter and Rosie Hails for their contributions to the opinion.

Type
Opinion of the Scientific Committee/Scientific Panel
Question Number
EFSA-Q-2005-278
EFSA-Q-2007-154
Adopted
30 January 2008
Published in the EFSA Journal
5 March 2008
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Abstract
No abstract available
Keywords
GMO, Brassica napus, oilseed rape, T45, glufosinate-ammonium herbicide, glufosinate-tolerant, pat gene, PAT protein, ACS-BNØØ8-2, human and animal health, environment, import, processing, Regulation (EC) No 1829/2003, renewal, existing product